Skip to main content

Table 4 Results of integrating pathway analysis with MetaboAnalyst 4.0

From: Metabolomics coupled with integrated approaches reveal the therapeutic effects of higenamine combined with [6]-gingerol on doxorubicin-induced chronic heart failure in rats

No

Pathway Name

Match status

p

− log(p)

Impact

1

Glycerophospholipid metabolism

3/36

0.00064401

7.3478

0.21631

2

Biosynthesis of unsaturated fatty acids

2/36

0.014161

4.2573

0

3

Fatty acid degradation

2/39

0.016523

4.103

0.12404

4

Linoleic acid metabolism

1/5

0.026263

3.6396

0

5

Alpha-Linolenic acid metabolism

1/13

0.067028

2.7026

0

6

Glycosylphosphatidylinositol (GPI)-anchor biosynthesis

1/14

0.072017

2.6308

0.00399

7

Pantothenate and CoA biosynthesis

1/19

0.096614

2.337

0.175

8

Citrate cycle (TCA cycle)

1/20

0.10146

2.288

0.08764

9

Pyruvate metabolism

1/22

0.1111

2.1973

0

10

Arachidonic acid metabolism

1/36

0.17603

1.7371

0

11

Fatty acid elongation

1/39

0.18939

1.6639

0

12

Fatty acid biosynthesis

1/47

0.2241

1.4957

0.01472